BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Agent, Bulking, Injectable For Gastro-Urology Use

    PMA: P000029 · Supplement: S001 · Decision Sep 23, 2002
    View on FDA
    Classifications
    1
    FEI Numbers
    16
    Registration Numbers
    16

    Basic Information

    Device Name
    Agent, Bulking, Injectable For Gastro-Urology Use
    Trade Name
    DEFLUX INJECTABLE GEL
    PMA Number
    P000029
    Supplement Number
    S001
    Device Class
    FDA Class 3
    Product Code
    LNM
    Generic Name
    AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
    Medical Specialty
    Unknown
    Advisory Committee
    Gastroenterology, Urology
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    September 23, 2002
    Date Received
    September 10, 2002
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    CHANGE IN THE SITE FOR BACTERIAL ENDOTOXIN TESTING OF CERTAIN COMPONENTS USED IN DEFLUX INJECTABLE GEL, INTENDED FOR TREATMENT OF VESICOURETERAL REFLUX IN CHILDREN.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    LNM Agent, Bulking, Injectable For Gastro-Urology Use